Prevalence of NAFLD (non-alcoholic fatty liver disease) affects approximately 25% of the entire US population. Of that, approximately six to eight percent may have Non-Alcoholic Steatohepatitis or NASH and thus this is the cohort of patients that have an increased risk for developing complications of end-stage liver disease over time or are also at risk of developing cardiovascular morbidity and mortality.
- Prof. M. F. Abdelmalek
- May 10, 2019
- More Epidemiology
- epidemiology
Would you like to read more?

Prof. M. F. Abdelmalek
Manal F. Abdelmalek, MD, MPH is Director of Hepatology and institutional lead for investigator-initiated and industry-sponsored multicenter clinical studies, Mayo Clinic, USA. Until recently, she was tenured Professor of Medicine in the Division of Gastroenterology and Hepatology at...